Search Results (390)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Schilsky, Richard | Person |
Why?
|
| Genetic basis of kidney cancer: a model for developing molecular-targeted therapies. | Academic Article |
Why?
|
| Novel molecular targeted therapies for refractory thyroid cancer. | Academic Article |
Why?
|
| Predicting response of molecular targeted therapies: a still possible challenge? | Academic Article |
Why?
|
| The promise of molecular targeted therapies: protein kinase inhibitors in the treatment of cutaneous malignancies. | Academic Article |
Why?
|
| Molecular Targeted Therapy | Concept |
Why?
|
| Salgia, Ravi | Person |
Why?
|
| Luke, Jason | Person |
Why?
|
| Piunti, Andrea | Person |
Why?
|
| A novel substituted aminoquinoline selectively targets voltage-sensitive sodium channel isoforms and NMDA receptor subtypes and alleviates chronic inflammatory and neuropathic pain. | Academic Article |
Why?
|
| A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis. | Academic Article |
Why?
|
| A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma. | Academic Article |
Why?
|
| A preclinical evaluation of neural stem cell-based cell carrier for targeted antiglioma oncolytic virotherapy. | Academic Article |
Why?
|
| A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies. | Academic Article |
Why?
|
| Adjuvant Therapy for Cutaneous Melanoma. | Academic Article |
Why?
|